3310 related articles for article (PubMed ID: 7549046)
21. A peptidomimetic antagonist of the integrin alpha(v)beta3 inhibits Leydig cell tumor growth and the development of hypercalcemia of malignancy.
Carron CP; Meyer DM; Pegg JA; Engleman VW; Nickols MA; Settle SL; Westlin WF; Ruminski PG; Nickols GA
Cancer Res; 1998 May; 58(9):1930-5. PubMed ID: 9581835
[TBL] [Abstract][Full Text] [Related]
22. Preferential antagonism of the interactions of the integrin alpha IIb beta 3 with immobilized glycoprotein ligands by snake-venom RGD (Arg-Gly-Asp) proteins. Evidence supporting a functional role for the amino acid residues flanking the tripeptide RGD in determining the inhibitory properties of snake-venom RGD proteins.
Lu X; Williams JA; Deadman JJ; Salmon GP; Kakkar VV; Wilkinson JM; Baruch D; Authi KS; Rahman S
Biochem J; 1994 Dec; 304 ( Pt 3)(Pt 3):929-36. PubMed ID: 7529494
[TBL] [Abstract][Full Text] [Related]
23. Characterization of the cross-linking site of disintegrins albolabrin, bitistatin, echistatin, and eristostatin on isolated human platelet integrin GPIIb/IIIa.
Calvete JJ; McLane MA; Stewart GJ; Niewiarowski S
Biochem Biophys Res Commun; 1994 Jul; 202(1):135-40. PubMed ID: 8037704
[TBL] [Abstract][Full Text] [Related]
24. [Conformational changes of the platelet membrane glycoprotein IIb-IIIa complex stimulated by a monoclonal antibody to the N-terminal segment of glycoprotein IIIa].
Khaspekova SG; Vyzova TV; Lukin VV; Tikhomirov OIu; Berndt M; Kouns W; Mazurov AV
Biokhimiia; 1996 Mar; 61(3):412-28. PubMed ID: 8724599
[TBL] [Abstract][Full Text] [Related]
25. Importance of the structure of the RGD-containing loop in the disintegrins echistatin and eristostatin for recognition of alpha IIb beta 3 and alpha v beta 3 integrins.
McLane MA; Vijay-Kumar S; Marcinkiewicz C; Calvete JJ; Niewiarowski S
FEBS Lett; 1996 Aug; 391(1-2):139-43. PubMed ID: 8706902
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of the metastasis of murine malignant melanoma by synthetic polymeric peptides containing core sequences of cell-adhesive molecules.
Saiki I; Iida J; Murata J; Ogawa R; Nishi N; Sugimura K; Tokura S; Azuma I
Cancer Res; 1989 Jul; 49(14):3815-22. PubMed ID: 2736523
[TBL] [Abstract][Full Text] [Related]
27. Characterization of the novel murine monoclonal anti-von Willebrand factor (vWf) antibody GUR76-23 which inhibits vWf interaction with alpha IIb beta 3 but not alpha v beta 3 integrin.
Yokoyama K; Handa M; Oda A; Katayama M; Fujimura Y; Murata M; Kawai Y; Watanabe K; Ikeda Y
Biochem Biophys Res Commun; 1997 May; 234(1):147-52. PubMed ID: 9168979
[TBL] [Abstract][Full Text] [Related]
28. Identification of CD47/integrin-associated protein and alpha(v)beta3 as two receptors for the alpha3(IV) chain of type IV collagen on tumor cells.
Shahan TA; Ziaie Z; Pasco S; Fawzi A; Bellon G; Monboisse JC; Kefalides NA
Cancer Res; 1999 Sep; 59(18):4584-90. PubMed ID: 10493512
[TBL] [Abstract][Full Text] [Related]
29. Mouse antithrombotic assay. Inhibition of platelet thromboembolism by disintegrins.
Beviglia L; Poggi A; Rossi C; McLane MA; Calabrese R; Scanziani E; Cook JJ; Niewiarowski S
Thromb Res; 1993 Aug; 71(4):301-15. PubMed ID: 8236159
[TBL] [Abstract][Full Text] [Related]
30. Measurement of glycoprotein IIb/IIIa blockade by flow cytometry with fluorescein isothiocyanate-conjugated crotavirin, a member of disintegrins.
Liu CZ; Hur BT; Huang TF
Thromb Haemost; 1996 Oct; 76(4):585-91. PubMed ID: 8903000
[TBL] [Abstract][Full Text] [Related]
31. Biochemical characterization of the binding of echistatin to integrin alphavbeta3 receptor.
Kumar CC; Nie H; Rogers CP; Malkowski M; Maxwell E; Catino JJ; Armstrong L
J Pharmacol Exp Ther; 1997 Nov; 283(2):843-53. PubMed ID: 9353406
[TBL] [Abstract][Full Text] [Related]
32. Limited T cell antigen receptor repertoire in tumor-infiltrating lymphocyte and inhibition of experimental lung metastasis of murine melanoma by anti-TCR antibody.
Wang R; Taniguchi M
J Immunol; 1995 Feb; 154(4):1797-803. PubMed ID: 7836764
[TBL] [Abstract][Full Text] [Related]
33. Suppression of experimental lung colonization of a metastatic variant of murine colon adenocarcinoma 26 by a monoclonal antibody 8F11 inhibiting tumor cell-induced platelet aggregation.
Sugimoto Y; Watanabe M; Oh-hara T; Sato S; Isoe T; Tsuruo T
Cancer Res; 1991 Feb; 51(3):921-5. PubMed ID: 1988132
[TBL] [Abstract][Full Text] [Related]
34. Modified heparins inhibit integrin alpha(IIb)beta(3) mediated adhesion of melanoma cells to platelets in vitro and in vivo.
Zhang C; Liu Y; Gao Y; Shen J; Zheng S; Wei M; Zeng X
Int J Cancer; 2009 Nov; 125(9):2058-65. PubMed ID: 19598263
[TBL] [Abstract][Full Text] [Related]
35. Cystine-knot peptides engineered with specificities for α(IIb)β(3) or α(IIb)β(3) and α(v)β(3) integrins are potent inhibitors of platelet aggregation.
Silverman AP; Kariolis MS; Cochran JR
J Mol Recognit; 2011; 24(1):127-35. PubMed ID: 21194123
[TBL] [Abstract][Full Text] [Related]
36. Pentoxifylline inhibits integrin-mediated adherence of 12(S)-HETE and TNFalpha-activated B16F10 cells to fibronectin and endothelial cells.
Jain M; Ratheesh A; Gude RP
Chemotherapy; 2010; 56(1):82-8. PubMed ID: 20299795
[TBL] [Abstract][Full Text] [Related]
37. Functional role of platelets in experimental metastasis studied with cloned murine fibrosarcoma cell variants.
Mahalingam M; Ugen KE; Kao KJ; Klein PA
Cancer Res; 1988 Mar; 48(6):1460-4. PubMed ID: 3345518
[TBL] [Abstract][Full Text] [Related]
38. Effects of prostacyclin on tumor cell-induced platelet aggregation.
Menter DG; Onoda JM; Taylor JD; Honn KV
Cancer Res; 1984 Feb; 44(2):450-6. PubMed ID: 6362850
[TBL] [Abstract][Full Text] [Related]
39. An in vivo study of the role of the tumor cell cytoskeleton in tumor cell-platelet-endothelial cell interactions.
Chopra H; Fligiel SE; Hatfield JS; Nelson KK; Diglio CA; Taylor JD; Honn KV
Cancer Res; 1990 Dec; 50(23):7686-96. PubMed ID: 2253213
[TBL] [Abstract][Full Text] [Related]
40. Triflavin, an Arg-Gly-Asp-containing antiplatelet peptide inhibits cell-substratum adhesion and melanoma cell-induced lung colonization.
Sheu JR; Lin CH; Chung JL; Teng CM; Huang TF
Jpn J Cancer Res; 1992 Aug; 83(8):885-93. PubMed ID: 1399825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
